Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy

URN:NBN:SI:doc-IGGQWJUE2025Hribernik, NežkaJeraj, RobertReberšek, MartinaStrašek, KatjaStuden, AndrejŠkalič, KatjaZevnik, Katarinadocuments/doc/I/URN_NBN_SI_doc-IGGQWJUE_001.pdfdocuments/doc/I/URN_NBN_SI_doc-IGGQWJUE_001.txt159articlestr. 43-5310.2478/raon-2025-00141318-2099224389123URN:NBN:SI:doc-IGGQWJUEengCroatian Medical Association - Croatian Society of RadiologySlovenian Medical Society - Section of RadiologyRadiology and oncology (Ljubljana)BYbiološki označevalciimmunotherapyimunoterapijamelanommelanomapreživetjeprognostic biomarkerssurvivalEarly-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy